Expert Q&A: Labs Must Take a Greater Role in Guiding Clinicians About Abnormal Data
Lee Fleisher, MD, advocates for clearer interpretation of test results by medical laboratory scientists
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Lee Fleisher, MD, advocates for clearer interpretation of test results by medical laboratory scientists
To ensure proper Medicare Part B billing and coding, your billing staff must be aware of all 22 of the newly recognized PLA codes.
Proper usage of ABN-related modifiers is a significant issue that has a direct impact on your lab’s reimbursement and compliance.
In this month’s roundup, three cases—including two whistleblower lawsuits and one workplace discrimination case—get dismissed.
Lab leaders must be able to make a sound assessment of both the costs and benefits, and the liability risks involved.
Labs have a duty to inquire into what their billing company is up to and whether it complies with all applicable regulations.
Recent Advisory Opinion sheds light on offering patients financial assistance so they can receive the provider’s products and services.
Resolution process put on hold after federal court again strikes down parts of the regulation as being unfairly weighted in favor of insurers.
Hopes are high that something will finally be done to resolve the LDTs situation this year, however that action may not come from Congress.
The agency recently issued new guidance exempting indirect independent diagnostic testing facilities from some requirements.
CMS recently proposed a rule that would make the False Claims Act rule the standard for overpayments under the Affordable Care Act regulations.